Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA-dextran conjugate

Anti-Cancer Drugs

Volumn 13, Issue 1, 2002, Pages 37-45

  Gervelas, C ^a   Avramoglou, T ^a   Crepin M ^a   Jozefonvicz, J ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Cytostatic agent; Growth inhibition; Human melanoma; Sodium phenylacetate; Substituted dextrans

Indexed keywords

CARBOXYMETHYLDEXTRAN; CYTOSTATIC AGENT; DEXTRAN; DEXTRAN DERIVATIVE; DEXTRAN METHYLCARBOXYLATE BENZYLAMIDE; PHENYLACETATE SODIUM; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MELANOMA; PRIORITY JOURNAL; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; CELL SURVIVAL; DEXTRANS; DRUG SYNERGISM; HUMANS; MELANOMA; MICE; MICE, NUDE; PHENYLACETATES; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036183666     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200201000-00004     Document Type: Article

References (33)

1. Mélanome
2. Phenylacetic acid as a potential therapeutic agent for the treatment of human cancer
3. A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer
4. Plasma protein binding of phenylacetate and phenylbutyrate, two novel antineoplastic agents
5. Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American Brain Tumor Consortium report
6. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate
7. Cytostatic activity of phenylacetate and derivatives against tumor cells. Correlation with lipophilicity and inhibition of protein prenylation
8. Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro
9. Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines
10. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination
11. Phenylacetate is an inhibitor of prostatic growth and development in organ culture
12. Selective activity of phenylacetate against malignant gliomas: Resemblance to fetal brain damage in phenylketonuria
13. Phenylacetate inhibits isoprenoid biosynthesis and suppresses growth of human pancreatic carcinoma
14. Phenylacetate in chemoprevention: In vitro and in vivo suppression of 5-aza-2′-deoxycytidine-induced carcinogenesis
15. Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: A review
16. Inhibitory effect of dextran derivatives in vitro on the growth characteristics of premalignant and malignant human mammary epithelial cell lines
17. Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice
18. Carboxymethyl benzylamide dextrans inhibit breast cell growth
19. Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: Blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB
20. Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF
21. Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): Interference with the FGF2 autocrine loop
22. Modulations of breast fibroblast and carcinoma cell interactions by a dextran derivative (CMDB7)
23. The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7)
24. VEGF165 activities are inhibited by carboxy methyl benzylamide dextran that competes for heparin binding to VEGF165 and VEGF165:KDR complexes
25. New investigations on heparin-like derivatized dextrans: CMDBS, synergistic role of benzylamide and sulfate substituents in anticoagulant activity
26. Anticoagulant properties of dextran-methylcarboxylate benzylamide sulfate (DMCBSu); a new generation of bioactive functionalized dextran
27. Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells
28. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin
29. Phenylacetate: A novel nontoxic inducer of tumor cell differentiation
30. Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate
31. Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines
32. Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents
33. 1 arrest and apoptosis in myeloid leukemia cells: Structure-function analysis